TEL AVIV, Israel and RALEIGH, N.C., March 30, 2023 — RedHill Biopharma Ltd. (NASDAQ: RDHL) […]
Viking Therapeutics Announces Pricing of $250 Million Public Offering of Common Stock
SAN DIEGO, March 29, 2023 — Viking Therapeutics, Inc. (“Viking”) (Nasdaq: VKTX), a clinical-stage […]
Viking Therapeutics Announces Proposed Public Offering of Common Stock
SAN DIEGO, March 29, 2023 — Viking Therapeutics, Inc. (“Viking”) (Nasdaq: VKTX), a clinical-stage […]
LOWE’S PRICES $3.0 BILLION NOTES OFFERING
MOORESVILLE, N.C., March 28, 2023 — Lowe’s Companies, Inc. (NYSE: LOW) announced today it has […]
Rexford Industrial Announces Pricing of $300 Million of 5.000% Senior Unsecured Notes due 2028
LOS ANGELES, March 28, 2023 — Rexford Industrial Realty, Inc. (the “Company” or “Rexford […]
Grupo IDESA, S.A. de C.V. Announces Offer to Exchange Existing Secured Notes for New Secured Notes and Cash Consideration
MEXICO CITY, March 28, 2023 — Grupo IDESA, S.A. de C.V. (the “Company”) today announced […]
Multi-Color Corporation Announces Launch of Senior Secured Notes Offering
CHICAGO, March 28, 2023 — Multi-Color Corporation (the “Company“), today announced the commencement of […]
TC BioPharm Announces Pricing of $5.5 Million Public Offering
EDINBURGH, Scotland, March 28, 2023 — TC BioPharm (Holdings) PLC (“TC BioPharm” or the […]
PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
SOUTH PLAINFIELD, N.J., March 28, 2023 — PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced […]